PSYCHOTHERAPY FOR ADOLESCENTS, CHildren AND ADULTS
According to a new survey conducted by researchers at Johns Hopkins Medicine, published Aug. 24 in the journal PLOS ONE, people’s attitudes about death change after both a psychedelic drug experience and a non-drug-related out-of-body experience.
People were less afraid of death than they had been before their experiences.
Read moreHere’s the latest on how psychedelics may help treat depression.
Read moreKeep reading for the facts and myths about psychedelics.
Read morePollan spoke with Rolling Stone about his new Netflix series, and why psychedelics have the potential to not only change your mind, but change the way our society approaches everything from wellness to climate change to spirituality.
Read moreAuthor Michael Pollan discusses the latest research in the psychedelic boom happening in medical research.
Read moreA recent follow-up study by Johns Hopkins Medicine researchers found two doses of the hallucinogenic compound coupled with psychotherapy resulted in large decreases in major depressive disorder symptoms for most of the study’s participants.
New research is hinting at how the hallucinogenic compound may facilitate reduced depression symptoms.
Read moreResearchers from SUNY Downstate Health Sciences University and McGill University published a paper in the journal Science Advances proposing a unique method for better understanding the interaction between hallucinogenic drugs, people’s brains, and different types of psychedelic experiences.
They did this by using artificial intelligence to look at real-life accounts of psychedelic experiences and compare them to how human brain chemistry engages with drugs on a molecular level.
However, while the researchers’ methods and goals push the envelope forward on understanding how psychedelics can help or harm individuals, the data they use could be unreliable.
Read moreBefore psychedelic therapy and services becomes widely available, there needs to be a better understanding of all the ways these experiences can go wrong.
Read moreThe NIH Workshop on Psychedelics as Therapeutics was conducted by the National Institute of Mental Health, the National Institute on Drug Abuse, and the National Institute on Alcohol Abuse and Alcoholism.
Read moreIn a conversation with Chris Wink, co-founder of Blue Man Group and creator of the psychedelic art exhibit Wink World, he discusses the nature of play and how it relates to art, life, and the psychedelic renaissance.
Read more